Skip to main content

Pharmacy Benefit Management Market 2021 Size, Share, Growth, Trends, Analysis, Competitive Analysis, Forecast Report 2020-2027

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Jan. 28, 2021 (GLOBE NEWSWIRE) — The global Pharmacy Benefit Management Market size is set to expand at a notable pace in the forthcoming years owing to the increasing efforts by creative enterprises to lower prescription drug prices, finds Fortune Business Insights™ in its report, titled “Pharmacy Benefit Management Market Size, Share & Industry Analysis, By Service (Specialty Pharmacy Services, Benefit Plan Design & Administration, Pharmacy Claims Processing, Formulary Management, Others), By Service Providers (Insurance Companies, Retail Pharmacies, Standalone PBMs) and Regional Forecast 2020-2027”.With prescription drugs becoming unaffordable without insurance cover, certain companies have been coming up with novel mechanisms to reduce medication costs and enhance price transparency of drugs. For example, GoodRx partners with PBMs and offers discounts through its coupons to people with no insurance and those with high deductible plans. Users can compare the price they would pay for a medication with a GoodRx coupon and the price offered by their insurance plan.Another emerging company in this space is Blink Health, which facilitates the purchase of low-cost generic drugs online and provides free pickup from local stores or free home delivery. Several other entities are slowly expanding their presence in this domain by collaborating with pharmacy benefit management companies and improving accessibility and affordability of costly medications.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pharmacy-benefit-management-pbm-market-103496
Booming Sales of Leading PBMs amid COVID-19 to Bolster Market GrowthThe COVID-19 pandemic has created an unprecedented health crisis, exerting tremendous strain of healthcare systems around the world. The pharmacy benefit management market growth is getting accelerated amid this crisis as the demand for low-cost medications and comprehensive insurance plans has heightened worldwide. Some of the leading PBMs and health coverage companies in this market have been reporting staggering sales, with people stocking up medications to deal lockdowns and movement restrictions.For example, CVS Health Corp’s profits in the first quarter of 2020 spiked 41% as its same-store sales skyrocketed during the early stages of the coronavirus pandemic. Similarly, Cigna’s pharmacy benefit management unit, Express Scripts, reported a 20% rise in revenues in the third quarter of 2020, reaching USD 29.83 billion. The coronavirus has, therefore, generated wide opportunities for players in this market, with PBMs playing an important role in ensuring access to critical medication for patients.
Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/pharmacy-benefit-management-pbm-market-103496
Quick Adoption of Advanced Healthcare Technologies to Boost the North America MarketAmong regions, North America is expected to dominate the pharmacy benefit management market share in the foreseeable future due to the eager adoption of innovative healthcare technologies and platforms by doctors and patients alike in the region. In addition, the demand for prescription drugs is high in the US owing to the increasing prevalence of chronic diseases, such as diabetes and cancer. In Europe, the main market drivers are strong per capita health expenditure, robust healthcare IT infrastructure, and a comprehensive insurance ecosystem. On the other hand, in Asia Pacific, rising uptake of advanced health technologies is expected to propel the regional market.Introduction of Innovative Products to Electrify Market CompetitionTo gain a decisive edge in the competitive milieu of this market, key players are regularly introducing new and exciting products. Through these innovations, companies are able to diversify their portfolios and adding new customers to their existing clientele. Moreover, the new products are also allowing market leaders to deepen their footprint and expand their global horizons.
Quick Buy –  Pharmacy Benefit Management Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103496
Industry Development:January 2020: RxSense announced the release of RxIQ, its analytics solution designed to enhance its enterprise pharmacy benefit management platform, RxAgile. RxAgile provides PBMs and health plan managers with a cloud-based platform that can be customized as per client needs.
List of Key Players Covered in the Pharmacy Benefit Management Market Report:MedImpactCentene CorporationOptumRx, Inc.CVS HealthCIGNAAnthem, Inc.Express Scripts
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/pharmacy-benefit-management-pbm-market-103496
Global Pharmacy Benefit Management Market Segmentation:By Service            •              Specialty Pharmacy Services•              Benefit Plan Design & Administration•              Pharmacy Claims Processing•              Formulary Management•              OthersBy Service Providers          •              Insurance Companies•              Retail Pharmacies•              Standalone PBMsBy Geography      •              North America (USA, Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)•              Latin America (Brazil, Mexico, Rest of Latin America)•              Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/pharmacy-benefit-management-pbm-market-103496
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:External Defibrillator Market Share and Global Trend By Product (Automated External Defibrillator (AED), Manual and Semi-automatic External Defibrillator, Wearable External Defibrillator), By End User (Hospitals & Clinics, Schools and other Public Places) and Geography Forecast till 2026Defibrillators Market Share and Global Trend By Type (Implantable Cardioverter Defibrillator (ICD), Transvenous ICD, External Defibrillator) By End User(Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Geography Forecast till 2026Ophthalmic Lasers Market Share and Global Trend By Type (Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, Diode Lasers), Technology (Photodisruption, Selective Laser Trabeculoplasty, Photocoagulation), Application (Cataract Treatment, Glaucoma Treatment, Refractive Errors Treatment), End-User (Ophthalmic Laser Centers,Hospitals ) & Geography Forecast till 2026Surgical Robots Market Share and Global Trend By Application (General Surgery, Gynecology, Urology, Orthopedics, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others) and Geography Forecast till 2026Sedation In ICU Setting Market Share and Global Trend By Drug/Drug Class (Propofol, Benzodiazepams (Midazolam, etc.), Dexmedetomidine, Remifentanil), & Geography Forecast till 2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.